Global Erectile Dysfunction Oral Medications Market Growth 2022-2028
Sildenafil (Viagra), vardenafil (Levitra, Staxyn), tadalafil (Cialis) and avanafil (Stendra) are oral medications that reverse erectile dysfunction by enhancing the effects of nitric oxide, a natural chemical your body produces that relaxes muscles in the penis.
The global market for Erectile Dysfunction Oral Medications is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Erectile Dysfunction Oral Medications market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Erectile Dysfunction Oral Medications market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Erectile Dysfunction Oral Medications market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Erectile Dysfunction Oral Medications market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Erectile Dysfunction Oral Medications players cover Eli Lilly, Pfizer, Bayer, S.K. Chemicals and Teva Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Erectile Dysfunction Oral Medications market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Erectile Dysfunction Oral Medications market, with both quantitative and qualitative data, to help readers understand how the Erectile Dysfunction Oral Medications market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Erectile Dysfunction Oral Medications market and forecasts the market size by Type (Sildenafil, Tadalafil and Others), by Application (Hospital Pharmacies, Private Clinics, Retail Pharmacies and E-Commerce), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Sildenafil
Tadalafil
Others
Segmentation by application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Eli Lilly
Pfizer
Bayer
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
BaiYunShan General Factory
Yabang Pharmacy
Chapter Introduction
Chapter 1: Scope of Erectile Dysfunction Oral Medications, Research Methodology, etc.
Chapter 2: Executive Summary, global Erectile Dysfunction Oral Medications market size (sales and revenue) and CAGR, Erectile Dysfunction Oral Medications market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Erectile Dysfunction Oral Medications sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Erectile Dysfunction Oral Medications sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Erectile Dysfunction Oral Medications market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Eli Lilly, Pfizer, Bayer, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma and BaiYunShan General Factory, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Erectile Dysfunction Oral Medications Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Erectile Dysfunction Oral Medications by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Erectile Dysfunction Oral Medications by Country/Region, 2017, 2022 & 2028
2.2 Erectile Dysfunction Oral Medications Segment by Type
2.2.1 Sildenafil
2.2.2 Tadalafil
2.2.3 Others
2.3 Erectile Dysfunction Oral Medications Sales by Type
2.3.1 Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
2.3.2 Global Erectile Dysfunction Oral Medications Revenue and Market Share by Type (2017-2022)
2.3.3 Global Erectile Dysfunction Oral Medications Sale Price by Type (2017-2022)
2.4 Erectile Dysfunction Oral Medications Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Private Clinics
2.4.3 Retail Pharmacies
2.4.4 E-Commerce
2.5 Erectile Dysfunction Oral Medications Sales by Application
2.5.1 Global Erectile Dysfunction Oral Medications Sale Market Share by Application (2017-2022)
2.5.2 Global Erectile Dysfunction Oral Medications Revenue and Market Share by Application (2017-2022)
2.5.3 Global Erectile Dysfunction Oral Medications Sale Price by Application (2017-2022)
3 Global Erectile Dysfunction Oral Medications by Company
3.1 Global Erectile Dysfunction Oral Medications Breakdown Data by Company
3.1.1 Global Erectile Dysfunction Oral Medications Annual Sales by Company (2020-2022)
3.1.2 Global Erectile Dysfunction Oral Medications Sales Market Share by Company (2020-2022)
3.2 Global Erectile Dysfunction Oral Medications Annual Revenue by Company (2020-2022)
3.2.1 Global Erectile Dysfunction Oral Medications Revenue by Company (2020-2022)
3.2.2 Global Erectile Dysfunction Oral Medications Revenue Market Share by Company (2020-2022)
3.3 Global Erectile Dysfunction Oral Medications Sale Price by Company
3.4 Key Manufacturers Erectile Dysfunction Oral Medications Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erectile Dysfunction Oral Medications Product Location Distribution
3.4.2 Players Erectile Dysfunction Oral Medications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Erectile Dysfunction Oral Medications by Geographic Region
4.1 World Historic Erectile Dysfunction Oral Medications Market Size by Geographic Region (2017-2022)
4.1.1 Global Erectile Dysfunction Oral Medications Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Erectile Dysfunction Oral Medications Annual Revenue by Geographic Region
4.2 World Historic Erectile Dysfunction Oral Medications Market Size by Country/Region (2017-2022)
4.2.1 Global Erectile Dysfunction Oral Medications Annual Sales by Country/Region (2017-2022)
4.2.2 Global Erectile Dysfunction Oral Medications Annual Revenue by Country/Region
4.3 Americas Erectile Dysfunction Oral Medications Sales Growth
4.4 APAC Erectile Dysfunction Oral Medications Sales Growth
4.5 Europe Erectile Dysfunction Oral Medications Sales Growth
4.6 Middle East & Africa Erectile Dysfunction Oral Medications Sales Growth
5 Americas
5.1 Americas Erectile Dysfunction Oral Medications Sales by Country
5.1.1 Americas Erectile Dysfunction Oral Medications Sales by Country (2017-2022)
5.1.2 Americas Erectile Dysfunction Oral Medications Revenue by Country (2017-2022)
5.2 Americas Erectile Dysfunction Oral Medications Sales by Type
5.3 Americas Erectile Dysfunction Oral Medications Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erectile Dysfunction Oral Medications Sales by Region
6.1.1 APAC Erectile Dysfunction Oral Medications Sales by Region (2017-2022)
6.1.2 APAC Erectile Dysfunction Oral Medications Revenue by Region (2017-2022)
6.2 APAC Erectile Dysfunction Oral Medications Sales by Type
6.3 APAC Erectile Dysfunction Oral Medications Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erectile Dysfunction Oral Medications by Country
7.1.1 Europe Erectile Dysfunction Oral Medications Sales by Country (2017-2022)
7.1.2 Europe Erectile Dysfunction Oral Medications Revenue by Country (2017-2022)
7.2 Europe Erectile Dysfunction Oral Medications Sales by Type
7.3 Europe Erectile Dysfunction Oral Medications Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erectile Dysfunction Oral Medications by Country
8.1.1 Middle East & Africa Erectile Dysfunction Oral Medications Sales by Country (2017-2022)
8.1.2 Middle East & Africa Erectile Dysfunction Oral Medications Revenue by Country (2017-2022)
8.2 Middle East & Africa Erectile Dysfunction Oral Medications Sales by Type
8.3 Middle East & Africa Erectile Dysfunction Oral Medications Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erectile Dysfunction Oral Medications
10.3 Manufacturing Process Analysis of Erectile Dysfunction Oral Medications
10.4 Industry Chain Structure of Erectile Dysfunction Oral Medications
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erectile Dysfunction Oral Medications Distributors
11.3 Erectile Dysfunction Oral Medications Customer
12 World Forecast Review for Erectile Dysfunction Oral Medications by Geographic Region
12.1 Global Erectile Dysfunction Oral Medications Market Size Forecast by Region
12.1.1 Global Erectile Dysfunction Oral Medications Forecast by Region (2023-2028)
12.1.2 Global Erectile Dysfunction Oral Medications Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Erectile Dysfunction Oral Medications Forecast by Type
12.7 Global Erectile Dysfunction Oral Medications Forecast by Application
13 Key Players Analysis
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Erectile Dysfunction Oral Medications Product Offered
13.1.3 Eli Lilly Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Erectile Dysfunction Oral Medications Product Offered
13.2.3 Pfizer Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Erectile Dysfunction Oral Medications Product Offered
13.3.3 Bayer Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 S.K. Chemicals
13.4.1 S.K. Chemicals Company Information
13.4.2 S.K. Chemicals Erectile Dysfunction Oral Medications Product Offered
13.4.3 S.K. Chemicals Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 S.K. Chemicals Main Business Overview
13.4.5 S.K. Chemicals Latest Developments
13.5 Teva Pharma
13.5.1 Teva Pharma Company Information
13.5.2 Teva Pharma Erectile Dysfunction Oral Medications Product Offered
13.5.3 Teva Pharma Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva Pharma Main Business Overview
13.5.5 Teva Pharma Latest Developments
13.6 Dong-A ST
13.6.1 Dong-A ST Company Information
13.6.2 Dong-A ST Erectile Dysfunction Oral Medications Product Offered
13.6.3 Dong-A ST Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dong-A ST Main Business Overview
13.6.5 Dong-A ST Latest Developments
13.7 Petros Pharmaceuticals
13.7.1 Petros Pharmaceuticals Company Information
13.7.2 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Offered
13.7.3 Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Petros Pharmaceuticals Main Business Overview
13.7.5 Petros Pharmaceuticals Latest Developments
13.8 Seoul Pharma
13.8.1 Seoul Pharma Company Information
13.8.2 Seoul Pharma Erectile Dysfunction Oral Medications Product Offered
13.8.3 Seoul Pharma Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Seoul Pharma Main Business Overview
13.8.5 Seoul Pharma Latest Developments
13.9 BaiYunShan General Factory
13.9.1 BaiYunShan General Factory Company Information
13.9.2 BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Offered
13.9.3 BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 BaiYunShan General Factory Main Business Overview
13.9.5 BaiYunShan General Factory Latest Developments
13.10 Yabang Pharmacy
13.10.1 Yabang Pharmacy Company Information
13.10.2 Yabang Pharmacy Erectile Dysfunction Oral Medications Product Offered
13.10.3 Yabang Pharmacy Erectile Dysfunction Oral Medications Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Yabang Pharmacy Main Business Overview
13.10.5 Yabang Pharmacy Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Erectile Dysfunction Oral Medications Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Erectile Dysfunction Oral Medications Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Sildenafil
Table 4. Major Players of Tadalafil
Table 5. Major Players of Others
Table 6. Global Erectile Dysfunction Oral Medications Sales by Type (2017-2022) & (K Units)
Table 7. Global Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
Table 8. Global Erectile Dysfunction Oral Medications Revenue by Type (2017-2022) & ($ million)
Table 9. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2017-2022)
Table 10. Global Erectile Dysfunction Oral Medications Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Erectile Dysfunction Oral Medications Sales by Application (2017-2022) & (K Units)
Table 12. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Table 13. Global Erectile Dysfunction Oral Medications Revenue by Application (2017-2022)
Table 14. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application (2017-2022)
Table 15. Global Erectile Dysfunction Oral Medications Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Erectile Dysfunction Oral Medications Sales by Company (2020-2022) & (K Units)
Table 17. Global Erectile Dysfunction Oral Medications Sales Market Share by Company (2020-2022)
Table 18. Global Erectile Dysfunction Oral Medications Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Erectile Dysfunction Oral Medications Revenue Market Share by Company (2020-2022)
Table 20. Global Erectile Dysfunction Oral Medications Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Erectile Dysfunction Oral Medications Producing Area Distribution and Sales Area
Table 22. Players Erectile Dysfunction Oral Medications Products Offered
Table 23. Erectile Dysfunction Oral Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Erectile Dysfunction Oral Medications Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Erectile Dysfunction Oral Medications Sales Market Share Geographic Region (2017-2022)
Table 28. Global Erectile Dysfunction Oral Medications Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Erectile Dysfunction Oral Medications Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Erectile Dysfunction Oral Medications Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Erectile Dysfunction Oral Medications Sales Market Share by Country/Region (2017-2022)
Table 32. Global Erectile Dysfunction Oral Medications Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Erectile Dysfunction Oral Medications Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Erectile Dysfunction Oral Medications Sales by Country (2017-2022) & (K Units)
Table 35. Americas Erectile Dysfunction Oral Medications Sales Market Share by Country (2017-2022)
Table 36. Americas Erectile Dysfunction Oral Medications Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Erectile Dysfunction Oral Medications Revenue Market Share by Country (2017-2022)
Table 38. Americas Erectile Dysfunction Oral Medications Sales by Type (2017-2022) & (K Units)
Table 39. Americas Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
Table 40. Americas Erectile Dysfunction Oral Medications Sales by Application (2017-2022) & (K Units)
Table 41. Americas Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Table 42. APAC Erectile Dysfunction Oral Medications Sales by Region (2017-2022) & (K Units)
Table 43. APAC Erectile Dysfunction Oral Medications Sales Market Share by Region (2017-2022)
Table 44. APAC Erectile Dysfunction Oral Medications Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Erectile Dysfunction Oral Medications Revenue Market Share by Region (2017-2022)
Table 46. APAC Erectile Dysfunction Oral Medications Sales by Type (2017-2022) & (K Units)
Table 47. APAC Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
Table 48. APAC Erectile Dysfunction Oral Medications Sales by Application (2017-2022) & (K Units)
Table 49. APAC Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Table 50. Europe Erectile Dysfunction Oral Medications Sales by Country (2017-2022) & (K Units)
Table 51. Europe Erectile Dysfunction Oral Medications Sales Market Share by Country (2017-2022)
Table 52. Europe Erectile Dysfunction Oral Medications Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Country (2017-2022)
Table 54. Europe Erectile Dysfunction Oral Medications Sales by Type (2017-2022) & (K Units)
Table 55. Europe Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
Table 56. Europe Erectile Dysfunction Oral Medications Sales by Application (2017-2022) & (K Units)
Table 57. Europe Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Erectile Dysfunction Oral Medications Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Erectile Dysfunction Oral Medications Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Erectile Dysfunction Oral Medications Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Erectile Dysfunction Oral Medications Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Erectile Dysfunction Oral Medications Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Erectile Dysfunction Oral Medications Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Erectile Dysfunction Oral Medications Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Erectile Dysfunction Oral Medications
Table 67. Key Market Challenges & Risks of Erectile Dysfunction Oral Medications
Table 68. Key Industry Trends of Erectile Dysfunction Oral Medications
Table 69. Erectile Dysfunction Oral Medications Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Erectile Dysfunction Oral Medications Distributors List
Table 72. Erectile Dysfunction Oral Medications Customer List
Table 73. Global Erectile Dysfunction Oral Medications Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Erectile Dysfunction Oral Medications Sales Market Forecast by Region
Table 75. Global Erectile Dysfunction Oral Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Erectile Dysfunction Oral Medications Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Erectile Dysfunction Oral Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Erectile Dysfunction Oral Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Erectile Dysfunction Oral Medications Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Erectile Dysfunction Oral Medications Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Erectile Dysfunction Oral Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Erectile Dysfunction Oral Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Erectile Dysfunction Oral Medications Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Erectile Dysfunction Oral Medications Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Erectile Dysfunction Oral Medications Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Erectile Dysfunction Oral Medications Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Erectile Dysfunction Oral Medications Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Erectile Dysfunction Oral Medications Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Erectile Dysfunction Oral Medications Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Erectile Dysfunction Oral Medications Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Erectile Dysfunction Oral Medications Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Erectile Dysfunction Oral Medications Revenue Market Share Forecast by Application (2023-2028)
Table 93. Eli Lilly Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 94. Eli Lilly Erectile Dysfunction Oral Medications Product Offered
Table 95. Eli Lilly Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Eli Lilly Main Business
Table 97. Eli Lilly Latest Developments
Table 98. Pfizer Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Erectile Dysfunction Oral Medications Product Offered
Table 100. Pfizer Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Bayer Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Erectile Dysfunction Oral Medications Product Offered
Table 105. Bayer Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. S.K. Chemicals Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 109. S.K. Chemicals Erectile Dysfunction Oral Medications Product Offered
Table 110. S.K. Chemicals Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. S.K. Chemicals Main Business
Table 112. S.K. Chemicals Latest Developments
Table 113. Teva Pharma Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 114. Teva Pharma Erectile Dysfunction Oral Medications Product Offered
Table 115. Teva Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Teva Pharma Main Business
Table 117. Teva Pharma Latest Developments
Table 118. Dong-A ST Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 119. Dong-A ST Erectile Dysfunction Oral Medications Product Offered
Table 120. Dong-A ST Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Dong-A ST Main Business
Table 122. Dong-A ST Latest Developments
Table 123. Petros Pharmaceuticals Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 124. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Product Offered
Table 125. Petros Pharmaceuticals Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Petros Pharmaceuticals Main Business
Table 127. Petros Pharmaceuticals Latest Developments
Table 128. Seoul Pharma Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 129. Seoul Pharma Erectile Dysfunction Oral Medications Product Offered
Table 130. Seoul Pharma Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Seoul Pharma Main Business
Table 132. Seoul Pharma Latest Developments
Table 133. BaiYunShan General Factory Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 134. BaiYunShan General Factory Erectile Dysfunction Oral Medications Product Offered
Table 135. BaiYunShan General Factory Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. BaiYunShan General Factory Main Business
Table 137. BaiYunShan General Factory Latest Developments
Table 138. Yabang Pharmacy Basic Information, Erectile Dysfunction Oral Medications Manufacturing Base, Sales Area and Its Competitors
Table 139. Yabang Pharmacy Erectile Dysfunction Oral Medications Product Offered
Table 140. Yabang Pharmacy Erectile Dysfunction Oral Medications Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Yabang Pharmacy Main Business
Table 142. Yabang Pharmacy Latest Developments
List of Figures
Figure 1. Picture of Erectile Dysfunction Oral Medications
Figure 2. Erectile Dysfunction Oral Medications Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Erectile Dysfunction Oral Medications Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Erectile Dysfunction Oral Medications Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Erectile Dysfunction Oral Medications Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Sildenafil
Figure 10. Product Picture of Tadalafil
Figure 11. Product Picture of Others
Figure 12. Global Erectile Dysfunction Oral Medications Sales Market Share by Type in 2021
Figure 13. Global Erectile Dysfunction Oral Medications Revenue Market Share by Type (2017-2022)
Figure 14. Erectile Dysfunction Oral Medications Consumed in Hospital Pharmacies
Figure 15. Global Erectile Dysfunction Oral Medications Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Erectile Dysfunction Oral Medications Consumed in Private Clinics
Figure 17. Global Erectile Dysfunction Oral Medications Market: Private Clinics (2017-2022) & (K Units)
Figure 18. Erectile Dysfunction Oral Medications Consumed in Retail Pharmacies
Figure 19. Global Erectile Dysfunction Oral Medications Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 20. Erectile Dysfunction Oral Medications Consumed in E-Commerce
Figure 21. Global Erectile Dysfunction Oral Medications Market: E-Commerce (2017-2022) & (K Units)
Figure 22. Global Erectile Dysfunction Oral Medications Sales Market Share by Application (2017-2022)
Figure 23. Global Erectile Dysfunction Oral Medications Revenue Market Share by Application in 2021
Figure 24. Erectile Dysfunction Oral Medications Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Erectile Dysfunction Oral Medications Revenue Market Share by Company in 2021
Figure 26. Global Erectile Dysfunction Oral Medications Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Erectile Dysfunction Oral Medications Revenue Market Share by Geographic Region in 2021
Figure 28. Global Erectile Dysfunction Oral Medications Sales Market Share by Region (2017-2022)
Figure 29. Global Erectile Dysfunction Oral Medications Revenue Market Share by Country/Region in 2021
Figure 30. Americas Erectile Dysfunction Oral Medications Sales 2017-2022 (K Units)
Figure 31. Americas Erectile Dysfunction Oral Medications Revenue 2017-2022 ($ Millions)
Figure 32. APAC Erectile Dysfunction Oral Medications Sales 2017-2022 (K Units)
Figure 33. APAC Erectile Dysfunction Oral Medications Revenue 2017-2022 ($ Millions)
Figure 34. Europe Erectile Dysfunction Oral Medications Sales 2017-2022 (K Units)
Figure 35. Europe Erectile Dysfunction Oral Medications Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Erectile Dysfunction Oral Medications Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Erectile Dysfunction Oral Medications Revenue 2017-2022 ($ Millions)
Figure 38. Americas Erectile Dysfunction Oral Medications Sales Market Share by Country in 2021
Figure 39. Americas Erectile Dysfunction Oral Medications Revenue Market Share by Country in 2021
Figure 40. United States Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Erectile Dysfunction Oral Medications Sales Market Share by Region in 2021
Figure 45. APAC Erectile Dysfunction Oral Medications Revenue Market Share by Regions in 2021
Figure 46. China Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Erectile Dysfunction Oral Medications Sales Market Share by Country in 2021
Figure 53. Europe Erectile Dysfunction Oral Medications Revenue Market Share by Country in 2021
Figure 54. Germany Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Erectile Dysfunction Oral Medications Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Erectile Dysfunction Oral Medications Revenue Market Share by Country in 2021
Figure 61. Egypt Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Erectile Dysfunction Oral Medications Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Erectile Dysfunction Oral Medications in 2021
Figure 67. Manufacturing Process Analysis of Erectile Dysfunction Oral Medications
Figure 68. Industry Chain Structure of Erectile Dysfunction Oral Medications
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets